Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing.
about
Concerning RNA-guided gene drives for the alteration of wild populationsCRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systemsMulti-OMICs and Genome Editing Perspectives on Liver Cancer Signaling NetworksRecent Advances in Genome Editing Using CRISPR/Cas9Customizing the genome as therapy for the β-hemoglobinopathiesThe CRISPR/Cas Genome-Editing Tool: Application in Improvement of CropsGenome Engineering with TALE and CRISPR Systems in NeuroscienceBrain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the futureThe therapeutic potential of genome editing for β-thalassemiaCRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic VirusesGenome-editing Technologies for Gene and Cell TherapyCRISPR/Cas9 and cancer targets: future possibilities and present challengesNuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off-target Effects in Genome EditingAdvanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the BrainGenome Editing and Its Applications in Model OrganismsTowards a new era in medicine: therapeutic genome editingTargeting Non-Coding RNAs in Plants with the CRISPR-Cas Technology is a Challenge yet Worth AcceptingResources for the design of CRISPR gene editing experimentsHow specific is CRISPR/Cas9 really?Origins of Programmable Nucleases for Genome EngineeringMinimizing off-Target Mutagenesis Risks Caused by Programmable NucleasesA new age in functional genomics using CRISPR/Cas9 in arrayed library screeningEnabling functional genomics with genome engineeringCurrent and future prospects for CRISPR-based tools in bacteriaEngineering large animal models of human diseaseDesigned nucleases for targeted genome editingUse of designer nucleases for targeted gene and genome editing in plantsBreaking bad: The mutagenic effect of DNA repairAdvances in CRISPR-Cas9 genome engineering: lessons learned from RNA interferenceOff-target Effects in CRISPR/Cas9-mediated Genome EngineeringEpigenome engineering in cancer: fairytale or a realistic path to the clinic?Making designer mutants in model organismsQuantifying on- and off-target genome editingRNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processesAdvances and perspectives in the application of CRISPR/Cas9 in insectsGenome editing: the road of CRISPR/Cas9 from bench to clinicPatterns of CRISPR/Cas9 activity in plants, animals and microbesRapid Evolution of Manifold CRISPR Systems for Plant Genome EditingThe application of genome editing in studying hearing lossChromatin regulation at the frontier of synthetic biology
P2860
Q21128771-9C718783-942A-4298-8704-B44AD838281DQ21558788-907BD95F-973E-41F8-AE93-202A37DEE2F3Q26741086-71B21437-7277-48B3-A22C-4AE3D32FE8F3Q26744073-E4818789-86AA-4B16-A831-CD8336DA4D99Q26751061-75465A97-82EF-4E8F-B1C1-96AF381AE3EEQ26752469-2B3E53D5-E54E-4465-A46C-BC413AD0DB9CQ26752488-C318BC48-4FD0-4483-B1C2-50247911A40FQ26753206-1A5E9E02-4DCA-4E55-9D05-E294CA4444C1Q26766232-20B67166-26FE-4967-A6F5-219BF23B5870Q26766798-45EABF08-4859-4A19-A71F-0177665EE984Q26769662-CF08F666-C588-4093-B89C-49FA9FC42212Q26769907-640DCA82-0DFB-4E24-8984-95875E9E1A80Q26770012-2D835DCA-2D93-4BE4-AD9D-4B624F6C6C66Q26770355-10575326-814A-4B59-A80C-BDCBBDDAAF48Q26772108-747ED19F-8434-403B-890D-2AE479A0A824Q26773287-D93BC8FB-913E-4B4D-A269-C9926A1CC2DBQ26774632-3468707D-2CC9-4528-91F9-05B974159592Q26776435-A80A6400-4517-4400-BCCD-089EFD0C7D2AQ26777801-BDF2C4D9-4E2E-4DAC-9E5D-ACDD5AC90AF7Q26778501-1B5A08CC-9D8A-49F7-A0C0-B9F0FD2FF2E5Q26778992-342AAFB7-6A36-4CDE-BC28-58BF399CE167Q26781135-7A451ACB-E5D8-4A05-8978-4341973F7771Q26782747-731E3F01-8F12-4837-BFDE-72F6FA8AE61CQ26783837-36539E80-01FE-4124-B718-8EB22577FE8EQ26785547-6C342DD6-359C-4E1D-8F00-CFAEE02D08B4Q26787105-A6175A1E-432C-43C7-BA6B-ADA07CBD88A8Q26799592-38448E44-E8BA-406C-AA3D-43869CFF16A1Q26827700-1ADC1842-9BBF-47F8-AAFF-B0DC03F5B3EEQ26852489-8B2071EB-66AF-4EC1-BDBE-69D854D70D3FQ26859390-22136430-2FE1-4979-AEC0-45D990239727Q26861350-D4B8D4A2-CC11-4FBC-B3CB-68103017DFFFQ27010108-F08AD329-F467-48DE-92A6-74694FE353EDQ27015049-D6548152-4893-4E48-BC80-20AD221682A3Q27025675-12531F83-5AF3-4068-A63F-67A93EA3DFA4Q27468938-C3017DDB-E4B9-4296-9282-69F1B203EA1AQ28066970-261E7328-65F6-4DC6-ABC3-91E9870337F7Q28078150-C36AE56D-912B-48C9-B034-976B4AB7EB21Q28079621-7AD9B414-AAA0-4E9C-B376-53D4DDC56F7AQ28081706-075CE6A0-F192-4295-9052-E00556C27C76Q28083608-74A54347-1736-43B6-B8DD-70B0C861F20D
P2860
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing.
@ast
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing.
@en
type
label
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing.
@ast
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing.
@en
prefLabel
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing.
@ast
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing.
@en
P2093
P2860
P356
P1433
P1476
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing.
@en
P2093
Cyd Khayter
Deepak Reyon
J Keith Joung
Jennifer A Foden
Martin J Aryee
Mathew J Goodwin
Nicolas Wyvekens
Shengdar Q Tsai
Vishal Thapar
P2860
P2888
P304
P356
10.1038/NBT.2908
P577
2014-04-25T00:00:00Z